Evidence map›Paper›PMID 41735386›Full record

ArticleScientific reports2026

AI based prediction of severe exacerbation in Asian bronchiectasis patients using the KMBARC registry.

Bumhee Yang, Sun-Hyung Kim, Geun-Hyeong Kim, Geonhui Min, Inyoung Jang, Dong Eun Kye, Kyungsang Kim, Ji Ye Jung, Ju Ock Na, Seung Park and 1 more

Abstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bumhee Yang *Division of Pulmonary and Critical Care Medicine, Department of Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, 776, 1sunhwan-ro, Seowon-gu, Cheongju, 28644, Republic of Korea.
Sun-Hyung Kim *Division of Pulmonary and Critical Care Medicine, Department of Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, 776, 1sunhwan-ro, Seowon-gu, Cheongju, 28644, Republic of Korea.
Geun-Hyeong Kim *The Medical Artificial Intelligence Center, Chungbuk National University Hospital, Chungbuk National University College of Medicine, 776, 1sunhwan-ro, Seowon-gu, Cheongju, 28644, Republic of Korea.
Geonhui MinDepartment of Biochemistry, Chungbuk National University College of Medicine, 1, Chungdae-ro, Seowon-gu, Cheongju, 28644, Republic of Korea.
Inyoung JangDepartment of Medicine, Chungbuk National University College of Medicine, 1, Chungdae-ro, Seowon-gu, Cheongju, 28644, Republic of Korea.
Dong Eun KyeDepartment of Medicine, Chungbuk National University College of Medicine, 1, Chungdae-ro, Seowon-gu, Cheongju, 28644, Republic of Korea.
Kyungsang KimCenter for Advanced Medical Computing and Analysis, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Ji Ye JungDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1, Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.
Ju Ock NaDivision of Pulmonology, Department of Internal Medicine, Soonchunhyang University, College of Medicine, 44, soonchunhyang 4-gil, Dongnam-gu, Cheonan, 31151, Korea.
Seung Park *The Medical Artificial Intelligence Center, Chungbuk National University Hospital, Chungbuk National University College of Medicine, 776, 1sunhwan-ro, Seowon-gu, Cheongju, 28644, Republic of Korea.
Hyun Lee *Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, 222-1, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Republic of Korea. namuhanayeyo@naver.com.

Funding

the Ministry of Education(MOE) and the (Chungcheongbuk-do), Republic of Korea 2025-RISE-11-014-03
6 · The paper itself

Abstract

Classical scoring tools such as the Bronchiectasis Severity Index (BSI) and FACED have shown good performance for predicting adverse outcomes, yet they were developed using European cohorts and may not fully align with Asian clinical characteristics. This study aimed to develop an Asian population–specific artificial intelligence (AI) model for predicting severe acute exacerbations (AEs) in bronchiectasis. A total of 492 patients with 1-year follow-up data from the Korean Multicenter Bronchiectasis Audit and Research Collaboration registry were analyzed. Severe AE was defined as an event requiring an emergency department visit or hospitalization due to worsening respiratory symptoms. Three AI models—extreme gradient boosting, logistic regression, and multilayer perceptron (MLP)—were trained and compared with classical scoring models. Severe AE occurred in 56 patients (11.4%). Among the models, the MLP demonstrated the best performance, with higher sensitivity, specificity, F1-score, and area under the receiver operating characteristic curve compared with both classical scores. Shapley additive explanation (SHAP) analysis identified BSI, sputum characteristics, and histories of tuberculosis and pneumonia as key predictors. Although classical scores performed well, a population-specific AI model using local clinical data showed improved predictive performance and may support individualized risk assessment for Asian patients with bronchiectasis.

Indexed as

Artificial IntelligenceBronchiectasisAgedAsian PeopleDisease ProgressionFemaleHospitalizationHumansLogistic ModelsMaleMiddle AgedMultilayer PerceptronsPrediction AlgorithmsRegistriesRepublic of KoreaROC CurveAcute exacerbationArtificial intelligenceBronchiectasisPrediction

Identifiers

PMID41735386
PMCPMC13043856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.